Safety of inhaled long-acting anti-muscarinic agents in COPD
NA Hanania, SC Lareau, BP Yawn - Postgraduate Medicine, 2017 - Taylor & Francis
Evidence-based guidelines recommend inhaled long-acting anti-muscarinic agents
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …
Safety of inhaled long-acting anti-muscarinic agents in COPD
NA Hanania, SC Lareau… - Postgraduate …, 2017 - pubmed.ncbi.nlm.nih.gov
Evidence-based guidelines recommend inhaled long-acting anti-muscarinic agents
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …
Safety of inhaled long-acting anti-muscarinic agents in COPD.
NA Hanania, SC Lareau, BP Yawn - Postgraduate Medicine, 2017 - europepmc.org
Evidence-based guidelines recommend inhaled long-acting anti-muscarinic agents
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …
(LAMAs) as first-line maintenance therapy for symptomatic patients with COPD. Several …